Sheaff Brock Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-101,500
| Closed | -$2.73M | – | 484 |
|
|
2019
Q1 | $2.73M | Buy |
101,500
+1,500
| +2% | +$40.3K | 0.33% | 66 |
|
|
2018
Q4 | $1.62M | Buy |
100,000
+27,500
| +38% | +$445K | 0.25% | 81 |
|
|
2018
Q3 | $1.51M | Buy |
72,500
+22,500
| +45% | +$467K | 0.14% | 97 |
|
|
2018
Q2 | $764K | Hold |
50,000
| – | – | 0.07% | 184 |
|
|
2018
Q1 | $1.12M | Hold |
50,000
| – | – | 0.12% | 130 |
|
|
2017
Q4 | $1.51M | Hold |
50,000
| – | – | 0.2% | 104 |
|
|
2017
Q3 | $1.88M | Sell |
50,000
-1,000
| -2% | -$37.7K | 0.25% | 92 |
|
|
2017
Q2 | $1.42M | Buy |
51,000
+1,000
| +2% | +$27.9K | 0.19% | 109 |
|
|
2017
Q1 | $1.72M | Hold |
50,000
| – | – | 0.22% | 95 |
|
|
2016
Q4 | $1.44M | Hold |
50,000
| – | – | 0.18% | 111 |
|
|
2016
Q3 | $1.59M | Hold |
50,000
| – | – | 0.21% | 96 |
|
|
2016
Q2 | $1.62M | Sell |
50,000
-3,000
| -6% | -$97.4K | 0.21% | 99 |
|
|
2016
Q1 | $1.48M | Hold |
53,000
| – | – | 0.18% | 114 |
|
|
2015
Q4 | $1.89M | Buy |
+53,000
| New | +$1.89M | 0.21% | 113 |
|